Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

NCT02914158 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

680

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Goserelin
DRUG: Tamoxifen
DRUG: Aromatase Inhibitors
DRUG: Leuprolide

Sponsor

First Affiliated Hospital, Sun Yat-Sen University